Professionals’ Networked Community Platform; Cannabis Connect™
Cannabis Connect™ is the leading Professionals’ Networked Community (PNC) platform for Cannabis and Hemp value chain organizations, the management and workforces which run them, their partners, suppliers and customers which support and interact with them.Join Us
Our Professionals’ Networked Community (PNC) platform, Cannabis ConnectTM, is organized using five (5) levels, or tiers.
Each Tier has a specific orientation and strength, as well as a set of unique functions and capabilities.
As you progress from one Tier to another, you gain access to additional States (or Territories, Provinces and Countries) based on which Member organization you start with.Read More
Ducats & Alms™
A Cannabis Connect™ Gaming System
We have embedded the Ducats and Alms™ gaming system within our Cannabis Connect™ platform. This section covers the basic Game Rules & Game Shop Pavilion objectives. We invite our Members to help us fine tune this unique game and move it towards a more broad-based content and knowledge management system which grows everyones’ knowledge, skills and competencies.Read More
The American Association of Cannabis & Hemp (C+H) Value ChainsTM serves the herbal wellness and Cannabis and Hemp industries as well as addressing many other herbal wellness topics and knowledge management activities. We even have a Knowledge Management game called Ducats & AlmsTM, which makes it fun to work and discuss herbal wellness and value chain topics with others!Read More
The Canadian Association of Cannabis & Hemp (C+H) Value ChainsTM serves the herbal wellness and Cannabis and Hemp industries as well as addressing many other herbal wellness topics and knowledge management activities. We even have a Knowledge Management game called Ducats & AlmsTM, which makes it fun to work and discuss herbal wellness and value chain topics with others!Read More
The International Association of Cannabis & Hemp (C+H) Value ChainsTM serves the herbal wellness and Cannabis and Hemp industries as well as addressing many other herbal wellness topics and knowledge management activities. We even have a Knowledge Management game called Ducats & AlmsTM, which makes it fun to work and discuss herbal wellness and value chain topics with others!Read More
Recent Status UpdatesNo Recent Status Updates
Quality Management System (QMS) Controls, including quality statistics and Laboratory Information Management (LIMS) data tracking:
Firm Name: Isolocity.com
Isolocity’s end-to-end quality compliance software holistically integrates over a decade of experience using quality principles from internationally recognized standards such as ISO 9001:2015, GMP, and more. It harnesses the power of automation to reduce work and resources needed by up to 50%. Its secure cloud technology allows users to implement and comply with complex quality control measures – from anywhere.
Isolocity addresses quality management functions which span these value chain activities:
1.) Inventory management
2.) Internal audit reporting and internal controls self-assessments
3.) Plant /part inspection and statistical process control
4.) Corrective Actions and Preventative Actions (CAPA)
5.) Document management
6.) Supply chain management
7.) Risk management
8.) Regulatory compliance education and training
9.) Specification management
10.) Laboratory Information Management Systems (LIMS) integration
Note that Isolocity also addresses these two best practice methodologies...
HACCP - Hazard and Critical Control Point analysis
PFMEA - Process Failure Mode and Effects Analysis
This discussion thread focuses on the wide-ranging topology of our C+H value chain management software and service providers which supply the enterprise integration infrastructure for the progressive company interested in automating all aspects of their operations.
Primary functions include, but are not limited to, the following areas:
- Pharmaceutical Engineering / New Drug Introduction
- Chemical compound and molecular "design chain" knowledge management
- Intellectual Property (IP) creation and protection via patents (e.g. C+H edible recipes)
- Cultivation (e.g. Indoor growers, outdoor growers, micro-cultivators, soil cultivation, hydroponics, aeroponics, multi-ponics, etc.)
- Quality Management System (QMS) Controls, quality statistics and Laboratory Information Systems (LIMS) data tracking
- Manufacturing & Consumer Packaged Goods (CPG) processing (e.g. edibles and beverage process manufacturing, discrete CPG manufacturing, etc.)
- Distributors and wholesale e-commerce transaction management
- Retailers and e-commerce transaction management
- Regulatory tracking and compliance assessment / industry standards best practices
- Industry benchmarking analytics & product sales data tracking
- On-going Governance Risk Compliance (GRC) best practices and performance tracking
- Banking and financial services
- Insurance and re-insurance services
- Legal Services
- Capital Management and Investor Services
- Note: Please reference our Value Chain Management industry standards to add additional functions such as...
- Business process management
- Business rule management
- Requirements management
- Security management
- Alternative currency management and distributed (blockchain-enabled) general ledger technologies
In this thread, we'll be featuring major C+H solutions. These companies will further your understanding of just how significant your overall value chain is, when it comes to delivering strategic value for your shareholders and generating "the surprise and delight" needed across the broad C+H adult recreation and medicinal "customer experience" continuums!
Here's a note which was received by our team from Steve Hawkins over at the Marijuana Policy Project :
Today, Senate Majority Leader Chuck Schumer (D-NY), Sen. Cory Booker (D-NJ), and Sen. Ron Wyden (D-OR) introduced a draft of their long-anticipated legislation to end federal cannabis prohibition.
In short, the Cannabis Administration and Opportunity Act would deschedule cannabis by removing it from the list of federally controlled substances, empowering states to decide their own cannabis policies. It would also put equity at the foundation of federal reform by ensuring restorative justice to those people and communities hardest—and most unfairly—hit by cannabis prohibition through expunging prior convictions and records, allowing people to petition for resentencing, and removing collateral consequences for those who’ve been criminalized. In addition, the bill would implement a framework for responsible regulations and taxes, with some of the tax revenue dedicated to grants programs intended to help equity applicants and those most impacted by the war on cannabis. Read a summary here.
Please ask your members of Congress to support the Cannabis Administration and Opportunity Act!
Now that Democrats have the majority in both chambers, there’s a sense of hope among advocates that this kind of reform is attainable in this Congress. We’ll need to secure 60 votes in the Senate, which is a major undertaking, but certainly possible, representing a unique opportunity for politicians to work across the aisle and enact a commonsense policy that has broad popular support. And, although President Biden’s support for legalization has been lukewarm, Sen. Booker insists Biden’s stance in favor of “decriminalization” will be enough to advance the legislation.
But with 19 legal states, including over 43% of the U.S. population, and public support for support for legalization swelling to 69% in a recent Quinnipiac poll, something’s got to give. It’s hard to imagine that President Biden would veto a bipartisan cannabis reform bill should one land on his desk, especially given the role that cannabis prohibition plays in sustaining racial injustice in the U.S.
MPP has been advocating for ending prohibition for over 25 years, and we’ll continue to work alongside elected leaders and advocates in support of this comprehensive reform measure. Please urge your federal lawmakers to support this legislation. Then, share the action with your friends, family, and social networks. We’ll continue to keep you informed of the bill’s progress and further opportunities to take action.
Marijuana Policy Project
Wikipedia defines this threaded discussion area as follows:
Psychedelics are a class of hallucinogenic drugs whose primary effect is to trigger non-ordinary states of consciousness (known as psychedelic experiences or "trips") via serotonin 2A receptor agonism. This causes specific psychological, visual and auditory changes, and often a substantially altered state of consciousness. The "classical" psychedelics, the psychedelics with the largest scientific and cultural influence, are mescaline, LSD, psilocybin, and DMT.
Most psychedelic drugs fall into one of the three families of chemical compounds: tryptamines, phenethylamines, or lysergamides. These chemicals all bind to serotonin 5-HT2A receptors, which modulate the activity of key circuits in the brain involved with sensory perception and cognition, however the exact nature of how psychedelics induce changes in perception and cognition via the 5-HT2A receptor is still unknown, although reduced default mode network activity is likely a primary mechanism of action. The psychedelic experience is often compared to non-ordinary forms of consciousness such as those experienced in meditation, mystical experiences, and near-death experiences. The phenomenon of ego dissolution is often described as a key feature of the psychedelic experience.
Many psychedelic drugs are illegal worldwide under the UN conventions, with occasional exceptions for religious use or research contexts. Despite these controls, recreational use of psychedelics is common. Legal barriers have made the scientific study of psychedelics more difficult. Research has been conducted, however, and studies show that psychedelics are physiologically safe and do not lead to addiction. Studies conducted using psilocybin in a psychotherapeutic setting reveal that psychedelic drugs may assist with treating depression and alcohol addiction, and possibly also nicotine addiction. Although further research is needed, existing results are showing that psychedelics may be useful for treating certain forms of psychopathology.
We'd like to get your case studies and thoughts on this area in terms of wellness research and findings along with the newly listed companies who are championing this area of organic plant and synthesized chemical compounds.
Cannabis federal legalization now has a HUGE boost from Supreme Court Justice Clarence Thomas, who has termed the U.S. administration’s current stand on Cannabis Policy as "contradictory and unstable".
Justice Thomas’ comments are important as they focus on existing laws which are outdated and not in sync with the legal actions by many states where Cannabis has been legalized. A Federal Cannabis compliance roadmap is needed as well as a change in how Cannabis is scheduled as a Schedule l narcotic.
Marijuana is a schedule I drug under the Controlled Substance Act passed by the Congress in 1970. A schedule I drug is a dangerous substance that has no recognized medical use and that has a high potential for abuse.
Let us know how you feel about this situation?